Baseline levels of C-reactive protein and proinflammatory cytokines are not associated with early response to amisulpride in patients with First Episode Psychosis: the OPTiMiSE cohort study

Archive ouverte

Barbosa, Susana | Martinuzzi, Emanuela | Sommer, Iris, E | Dazzan, Paola | Mcguire, Philip | Arango, Celso | Diaz-Caneja, Covadonga, M | Fleischhacker, W Wolfgang, Wolfgang | Rujescu, Dan | Glenthøj, Birte | Winter-van Rossum, Inge | Kahn, René Sylvain | Yolken, Robert | Lewis, Shon | Drake, Richard | Leucht, Stefan | Gilet, Cyprien | Khalfallah, Olfa | Davidovic, Laetitia | Ibrahim, El Chérif | Belzeaux, Raoul | Leboyer, Marion | Glaichenhaus, Nicolas

Edité par CCSD ; Maryland Psychiatric Research Center/Oxford UP -

International audience. Abstract Background Patients with a First-Episode of Psychosis (FEP) exhibit low-grade inflammation as demonstrated by elevated levels of C reactive protein (CRP) and pro-inflammatory cytokines. Aims The primary goal of this study was to investigate the association between pro-inflammatory biomarkers and clinical outcomes in unmedicated FEP patients. Method We used clinical data and biological samples from 289 FEP patients participating to the Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE) clinical trial. Patients were assessed at baseline and 4-5 weeks after treatment with amisulpride. Baseline serum levels of interleukin (IL)-6, IL-8, Tumor Necrosis Factor (TNF)-α and CRP were measured. We first used multivariable regression to investigate the association between each of the four tested biomarkers and the following clinical outcomes: Positive And Negative Syndrome Scale (PANSS), Calgary Depression Score for Schizophrenia (CDSS), remission according to Andreasen’s criteria and Serious Adverse Events (SAEs). As a complementary approach, we used an unsupervised clustering method to stratify patients into an “inflamed” or a “non-inflamed” biotype based on baseline levels of IL-6, IL-8 and TNF-α. We then used linear and logistic regressions to investigate the association between the patient biotype and clinical outcomes. Results After adjusting for covariates and confounders, we did not find any association between IL-6, IL-8, TNF-α, CRP or the patient biotype and clinical outcomes. Implications Our results do not support the existence of an association between baseline levels of CRP and proinflammatory cytokines and early response to amisulpride in unmedicated FEP patients.

Suggestions

Du même auteur

Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study

Archive ouverte | Martinuzzi, Emanuela | CCSD

International audience. Early response to first-line antipsychotic treatments is strongly associated with positive long-term symptomatic and functional outcome in psychosis. Unfortunately, attempts to identify relia...

Correction: Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study

Archive ouverte | Martinuzzi, Emanuela | CCSD

International audience

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

Archive ouverte | Kahn, René S | CCSD

BACKGROUND : No established treatment algorithm exists for patients with schizophrenia. Whether switching antipsychotics or early use of clozapine improves outcome in (first-episode) schizophrenia is unknown. METHODS : This three-...

Chargement des enrichissements...